Perspectives in Antiinfective Therapy. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2) (German Edition) - Couverture souple
Synopsis
Pharmaceutical research has a long-standing tradition in Bayer since the estab- lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile- stone was marked by the discovery and launch of Aspirin (TM) in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com- pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin (TM) and Resochin (TM) were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil(TM), opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Perspectives in Antiinfective Therapy. (Current Topics...
Image d'archives
PERSPECTIVES IN ANTIINFECTIVE THERAPY. Current Topics in Infectious Diseases and Clinical Microbiology, Volume Two.
Edité par
Friedr Vieweg and Sohn, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Ancien ou d'occasion
Couverture souple
Vendeur : Zubal-Books, Since 1961, Cleveland, OH, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : Good. 310 pp., paperback, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country. N° de réf. du vendeur ZB611390
Acheter D'occasion
EUR 4,30
Expédition à EUR 3,76
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Perspectives in Antiinfective Therapy
Edité par
Vieweg+Teubner Verlag, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Ancien ou d'occasion
Couverture souple
Vendeur : Clivia Mueller, Isernhagen, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Current Topics in Infectious Diseases and Clinical Microbiology Volume 2. IX. 299 S. Quart. mit Abbildungen. ISBN: 3528079797. Vieweg. Braunschweig. 1989. Mit Gebrauchsspuren/Used condition. Broschur/Softcover. Sprache: englisch/english. N° de réf. du vendeur 2P2650
Acheter D'occasion
EUR 22,90
Expédition à EUR 24,10
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Perspectives in Antiinfective Therapy : Bayer Ag Centenary Symposium Washington, D. C., Aug. 31-sept. 3, 1988 -Language: german
Edité par
Vieweg+Teubner Verlag, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Couverture souple
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 21688195-n
Acheter neuf
EUR 66,79
Expédition à EUR 2,20
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 15 disponible(s)
Image d'archives
Perspectives in Antiinfective Therapy (Paperback)
Edité par
Friedrich Vieweg & Sohn Verlagsgesellschaft mbH, Wiesbaden, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Paperback
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. Pharmaceutical research has a long-standing tradition in Bayer since the estab- lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile- stone was marked by the discovery and launch of Aspirin (TM) in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com- pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin (TM) and Resochin (TM) were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil(TM), opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken. Pharmaceutical research has a long-standing tradition in Bayer since the estabA lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mileA stone was marked by the discovery and launch of Aspirin a in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical comA pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin a and Resochin a were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosila, opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe a Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9783528079796
Acheter neuf
EUR 69,05
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2)
Edité par
Vieweg+Teubner Verlag, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Couverture souple
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9783528079796_new
Acheter neuf
EUR 59,80
Expédition à EUR 13,83
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Perspectives in Antiinfective Therapy: Bayer AG Centenary Symposium Washington, D. C., Aug. 31 Sept. 3, 1988
Vendeur : Chiron Media, Wallingford, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
PF. Etat : New. N° de réf. du vendeur 6666-IUK-9783528079796
Acheter neuf
EUR 58,26
Expédition à EUR 17,88
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 10 disponible(s)
Image fournie par le vendeur
Perspectives in Antiinfective Therapy
Edité par
Vieweg & Teubner Verlag Jan 1989, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmaceutical research has a long-standing tradition in Bayer since the estab lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile stone was marked by the discovery and launch of Aspirin in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin and Resochin were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil , opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken. 312 pp. Deutsch. N° de réf. du vendeur 9783528079796
Acheter neuf
EUR 54,99
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
Perspectives in Antiinfective Therapy
Edité par
Vieweg+Teubner Verlag, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Couverture souple
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Editor(s): Jackson, G.G. BIC Classification: MB. Dimension: 280 x 210. Weight in Grams: 764. . 1989. Paperback. . . . . N° de réf. du vendeur V9783528079796
Acheter neuf
EUR 76,87
Expédition à EUR 10,50
Expédition depuis Irlande vers Etats-Unis
Expédition depuis Irlande vers Etats-Unis
Quantité disponible : 15 disponible(s)
Image d'archives
Perspectives in Antiinfective Therapy: Bayer Ag Centenary Symposium Washington, D. C., Aug. 31-sept. 3, 1988
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : Brand New. 308 pages. German language. 11.00x8.20x0.74 inches. In Stock. N° de réf. du vendeur x-3528079797
Acheter neuf
EUR 86,33
Expédition à EUR 14,43
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
Perspectives in Antiinfective Therapy
Edité par
Vieweg+Teubner Verlag, 1989
ISBN 10 : 3528079797
ISBN 13 : 9783528079796
Neuf
Couverture souple
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. Editor(s): Jackson, G.G. BIC Classification: MB. Dimension: 280 x 210. Weight in Grams: 764. . 1989. Paperback. . . . . Books ship from the US and Ireland. N° de réf. du vendeur V9783528079796
Acheter neuf
EUR 92,33
Expédition à EUR 8,77
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 15 disponible(s)